[go: up one dir, main page]

PA8671301A1 - Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización - Google Patents

Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización

Info

Publication number
PA8671301A1
PA8671301A1 PA20068671301A PA8671301A PA8671301A1 PA 8671301 A1 PA8671301 A1 PA 8671301A1 PA 20068671301 A PA20068671301 A PA 20068671301A PA 8671301 A PA8671301 A PA 8671301A PA 8671301 A1 PA8671301 A1 PA 8671301A1
Authority
PA
Panama
Prior art keywords
pirrolopiridins
replaced
compositions
contain
manufacturing
Prior art date
Application number
PA20068671301A
Other languages
English (en)
Inventor
Frank Halley
Ronan Baptiste
Michel Tabart
Eric Bacque
Catherine Souaille
Fabrice Viviani
Pascal Desmazeau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PA8671301A1 publication Critical patent/PA8671301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE PRINCIPALMENTE A LA PREPARACIÓN DE PIRROLOPIRIDINAS SUSTITUIDAS, A LAS COMPOSICIONES QUE LAS CONTIENEN, A SU PROCESO , EN ESPECIAL COMO AGENTES ANTICANCERÍGENOS.
PA20068671301A 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización PA8671301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
PA8671301A1 true PA8671301A1 (es) 2006-12-07

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20068671301A PA8671301A1 (es) 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización

Country Status (33)

Country Link
US (1) US7947706B2 (es)
EP (1) EP1877409B1 (es)
JP (1) JP2008539211A (es)
KR (1) KR20080007229A (es)
CN (1) CN101166739A (es)
AR (1) AR061386A1 (es)
AT (1) ATE433976T1 (es)
AU (1) AU2006239105A1 (es)
BR (1) BRPI0613161A2 (es)
CA (1) CA2605744A1 (es)
CR (1) CR9463A (es)
CY (1) CY1109369T1 (es)
DE (1) DE602006007337D1 (es)
DK (1) DK1877409T3 (es)
DO (1) DOP2006000096A (es)
EA (1) EA012983B1 (es)
ES (1) ES2328629T3 (es)
FR (1) FR2884821B1 (es)
GT (1) GT200600174A (es)
HR (1) HRP20090494T1 (es)
IL (1) IL186523A0 (es)
MA (1) MA29480B1 (es)
MX (1) MX2007013084A (es)
NO (1) NO20075918L (es)
PA (1) PA8671301A1 (es)
PE (1) PE20071420A1 (es)
PL (1) PL1877409T3 (es)
PT (1) PT1877409E (es)
RS (1) RS51136B (es)
SI (1) SI1877409T1 (es)
TN (1) TNSN07360A1 (es)
TW (1) TW200718701A (es)
WO (1) WO2006114520A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2010505962A (ja) * 2006-10-09 2010-02-25 武田薬品工業株式会社 キナーゼ阻害剤
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
HRP20151398T1 (hr) 2006-12-22 2016-02-12 Astex Therapeutics Limited Tricikliäśni derivati amina kao inhibitori protein tirozin kinaze
CN101679408B (zh) * 2006-12-22 2016-04-27 Astex治疗学有限公司 作为fgfr抑制剂的双环杂环化合物
BRPI0814423B1 (pt) 2007-07-17 2022-04-19 Plexxikon, Inc Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
MX2011008303A (es) 2009-04-03 2011-11-29 Plexxikon Inc Composiciones del acido propano-1-sulfonico {3-[5-(4-cloro-fenil)- 1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil}-amida y el uso de las mismas.
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
BR112012012156A2 (pt) 2009-11-06 2015-09-08 Plexxikon Inc compostos e métodos para modulação de cinase, e indicações para esta
AU2012214762B2 (en) 2011-02-07 2015-08-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
EP2855477A4 (en) * 2012-05-29 2015-11-18 Merck Sharp & Dohme ISOTOPICALLY MARKED BIARYL UREA COMPOUNDS
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
EP1425284A2 (en) * 2001-09-11 2004-06-09 Smithkline Beecham Corporation Furo- and thienopyrimidine derivatives as angiogenesis inhibitors
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
MXPA04003758A (es) * 2001-10-22 2005-06-20 Univ New York State Res Found Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos.
AU2003214412A1 (en) * 2002-03-28 2003-10-13 Eisai R & D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
FR2878849B1 (fr) * 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
BRPI0613161A2 (pt) 2010-12-21
HRP20090494T1 (hr) 2009-10-31
CA2605744A1 (fr) 2006-11-02
EP1877409A2 (fr) 2008-01-16
DOP2006000096A (es) 2007-04-15
DK1877409T3 (da) 2009-10-05
EA200702329A1 (ru) 2008-02-28
KR20080007229A (ko) 2008-01-17
WO2006114520A2 (fr) 2006-11-02
PL1877409T3 (pl) 2009-12-31
RS51136B (sr) 2010-10-31
US20080139606A1 (en) 2008-06-12
TNSN07360A1 (en) 2008-12-31
AR061386A1 (es) 2008-08-27
FR2884821A1 (fr) 2006-10-27
EP1877409B1 (fr) 2009-06-17
MA29480B1 (fr) 2008-05-02
PT1877409E (pt) 2009-09-16
ES2328629T3 (es) 2009-11-16
CR9463A (es) 2008-02-21
DE602006007337D1 (de) 2009-07-30
WO2006114520A3 (fr) 2007-03-01
EA012983B1 (ru) 2010-02-26
IL186523A0 (en) 2008-01-20
MX2007013084A (es) 2008-01-11
FR2884821B1 (fr) 2007-07-06
SI1877409T1 (sl) 2009-12-31
JP2008539211A (ja) 2008-11-13
CY1109369T1 (el) 2014-07-02
ATE433976T1 (de) 2009-07-15
US7947706B2 (en) 2011-05-24
TW200718701A (en) 2007-05-16
CN101166739A (zh) 2008-04-23
AU2006239105A1 (en) 2006-11-02
GT200600174A (es) 2006-12-26
NO20075918L (no) 2007-11-19
PE20071420A1 (es) 2007-01-20

Similar Documents

Publication Publication Date Title
PA8671301A1 (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
GT200600084A (es) Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
PA8842101A1 (es) Heteroarilos sustituidos
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
CR10060A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
SV2009003253A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
UY29248A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
UY29361A1 (es) Pirroles e imidazoles sustituídos, composiciones que los contienen, procedimiento de fabricación y utilización
HN2006029142A (es) Proceso
SV2006002384A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
UY29417A1 (es) Agentes endoparasiticidas
NI201200103A (es) NUEVOS DERIVADOS ( HETEROCICLO - TETRAHIDRO - PIRIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y ( HETEROCICLO - DIHIDRO - PIRROLIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75
CR9115A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
ECSP088893A (es) 2-alcoxi-3, 4,5-trihidroxi-alquilamida-benzazepinas, su preparación, composiciones que las contienen y utilización
ECSP088899A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparación, composiciones que las contienen y utilización
UY29501A1 (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización
ECSP088897A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización
UY29235A1 (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparación, composiciones que las contienen y utilización
DOP2005000246A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CL2014001344A1 (es) Un compuesto 5,5-dimetil-2-propil-hexahidro-2,4a-metano-naftalen-1-ona; composicion que lo comprende; y su uso como un agente o compuesto fragante, como agente enmascarante del olor o agente neutralizador del olor.